Clicky

INVO BioScience, Inc.(INVO)

Description: INVO Bioscience, Inc. is an innovative medical device company developing solutions for the global infertility industry. INVO's goal is to increase access to care and expand fertility treatment across the globe while seeking to lower the cost and increase the availability of care. INVO's lead commercial product, the INVOcell, is a patented Assisted Reproductive Technology (ART) used in the treatment of infertility. The INVOcell device and procedure is unique as the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. As an alternative to traditional in Vitro Fertilization (IVF), the revolutionary in vivo method of vaginal incubation offers patients a more natural and intimate experience. INVO Bioscience is headquartered in Sarasota, FL.


Keywords: In Vitro Human Reproduction Fertility Reproduction Vagina Eggs Infertility Fertility Medicine In Vitro Fertilisation Assisted Reproductive Technology In Vitro Fertilization Embryo Transfer Reproductive Technology Unexplained Infertility

Home Page: www.invobio.com

INVO Technical Analysis

5582 Broadcast Court
Sarasota, FL 34240
United States
Phone: 978 878 9505


Officers

Name Title
Mr. Steven M. Shum CEO & Director
Mr. Andrea Goren Chief Financial Officer
Mr. Michael Jos. Campbell COO & VP of Bus. Devel.
Dr. Kevin Doody M.D. Medical Director & Director
Mr. Bojan Mitrovic Ph.D. Director of Sales US
Dr. Barbara Levy F.A.C.S., FACOG, M.D. Sr. VP of Global Clinical Integration
Mr. Chris Myer Sr. VP of Bus. Devel. of Americas
Mr. Robert Joseph Bowdring Jr. Treasurer & Sec.
Ms. Terah Krigsvold Controller
Ms. Lori Marzilli-Kahler VP of Global Operations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 5.6708
Price-to-Sales TTM: 1.4563
IPO Date: 2012-05-21
Fiscal Year End: December
Full Time Employees: 10
Back to stocks